Ledger.Open graph →
SEC Form D · filed November 4, 2019

Bryn Pharma, LLC

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Dale Sander · Raleigh, NCExecKate Grell · Raleigh, NCDirectorSteven Hartman · Raleigh, NCExec · DirectorDavid Dworaczyk · Raleigh, NCExec · DirectorStephen Beckman · Raleigh, NCExecMichelle Lobel · Raleigh, NCExec · DirectorMiao Hong · Rockville, MDDirectorMartin Devenport · Rockville, MDExec · DirectorKun-Liang Guan · Rockville, MDExec · DirectorFarah Rehman · Houston, TXExecAvrohom G. Vann · Evanston, ILExecRajul Garg · Singapore, U0Exec · DirectorSwan E. Sit · EMERYVILLE, CAExec · DirectorXiaopei (Ray) Wang · EMERYVILLE, CAExec · DirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorPaul E. Freiman · EMERYVILLE, CAExecAndrew M. Jones · EMERYVILLE, CAExec · DirectorJeffrey Thompson · Newport, RIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗